GSK PLC
GSK
Pricing is indicative. Past performance is not a reliable indicator of future results. Client sentiment is provided for general information only, is historical in nature and is not intended to provide any form of trading or investment advice - it must not form the basis of your trading or investment decisions.
Trading Conditions
ATP Margin
0.03
Contract Size Currency per 1 Lot Symbol
1 Share
Min/Max Trade Size (lots)
100 Shares / 500000
Schedule and Fees
Market Open
Monday 08:00 London
Market Closed
Friday 16:30 London
Trading Break
12:00 - 12:02 & 16:30 - 08:00 London
3 Day Financing
Wednesday
Long & Short Position Overnight Fee
displayed on the trading platform
FAQ
GSK, or GlaxoSmithKline, is a multinational pharmaceutical and healthcare company with a significant global presence. Founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK has since established itself as one of the largest pharmaceutical companies worldwide.
GSK operates across multiple therapeutic areas, including pharmaceuticals, vaccines, and consumer healthcare products. Their pharmaceutical division is focused on developing and manufacturing a wide range of prescription medications to address various medical conditions, such as respiratory diseases, infectious diseases, and oncology. Additionally, GSK has an extensive portfolio of vaccines that are globally administered against various infectious diseases. The company is heavily involved in research and innovation, collaborating with academic institutions and research organisations to advance medical science. GSK's consumer healthcare segment offers over-the-counter products, including oral care, pain relief, and wellness items, catering to consumers' everyday health needs.
The company is headquartered in London, UK, and is listed on the London Stock Exchange (LSE) under the ticker symbol "GSK".
